Vaccination against the Epstein–Barr virus

Epstein–Barr virus (EBV) was the first human tumor virus being discovered and remains to date the only human pathogen that can transform cells in vitro. 55 years of EBV research have now brought us to the brink of an EBV vaccine. For this purpose, recombinant viral vectors and their heterologous pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühl, Julia, Leung, Carol S., Münz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223886/
https://www.ncbi.nlm.nih.gov/pubmed/32367191
http://dx.doi.org/10.1007/s00018-020-03538-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223886/
https://www.ncbi.nlm.nih.gov/pubmed/32367191
http://dx.doi.org/10.1007/s00018-020-03538-3

Ejemplares similares